Aprea Therapeutics's total assets for Q2 2025 were $17.31M, a decrease of -14.40% from the previous quarter. APRE total liabilities were $3.90M for the fiscal quarter, a -16.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.